Multidimensional response of Dupilumab in a child affected by Netherton syndrome: Improvement of trichorrhexis invaginata

Pediatr Allergy Immunol. 2023 Jul;34(7):e13997. doi: 10.1111/pai.13997.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Child
  • Dermatitis, Exfoliative*
  • Humans
  • Netherton Syndrome* / drug therapy

Substances

  • dupilumab
  • Antibodies, Monoclonal, Humanized